Market Closed -
Bombay S.E.
03:30:51 10/05/2024 pm IST
|
5-day change
|
1st Jan Change
|
279.2
INR
|
-0.52%
|
|
-5.47%
|
+1.34%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
791.2
|
1,462
|
761.1
|
896.1
|
829.6
|
2,147
|
Enterprise Value (EV)
1 |
1,175
|
1,798
|
725.1
|
971.6
|
828.2
|
1,696
|
P/E ratio
|
59.1
x
|
26.7
x
|
12.7
x
|
11.1
x
|
13.4
x
|
3.81
x
|
Yield
|
-
|
-
|
2.06%
|
-
|
1.42%
|
2.92%
|
Capitalization / Revenue
|
0.48
x
|
0.65
x
|
0.29
x
|
0.37
x
|
0.29
x
|
0.48
x
|
EV / Revenue
|
0.71
x
|
0.8
x
|
0.28
x
|
0.41
x
|
0.29
x
|
0.38
x
|
EV / EBITDA
|
14.5
x
|
12.3
x
|
3.38
x
|
4.79
x
|
8.88
x
|
2.17
x
|
EV / FCF
|
48.5
x
|
107
x
|
2.11
x
|
-6.26
x
|
13.5
x
|
10.6
x
|
FCF Yield
|
2.06%
|
0.94%
|
47.4%
|
-16%
|
7.38%
|
9.45%
|
Price to Book
|
1.17
x
|
2
x
|
0.98
x
|
1.05
x
|
0.91
x
|
1.47
x
|
Nbr of stocks (in thousands)
|
7,830
|
7,830
|
7,830
|
7,830
|
7,830
|
7,830
|
Reference price
2 |
101.0
|
186.7
|
97.20
|
114.4
|
106.0
|
274.2
|
Announcement Date
|
24/08/18
|
14/08/19
|
07/09/20
|
11/08/21
|
10/08/22
|
23/08/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,645
|
2,237
|
2,636
|
2,392
|
2,898
|
4,439
|
EBITDA
1 |
81.26
|
146.1
|
214.6
|
202.9
|
93.31
|
779.8
|
EBIT
1 |
74.41
|
140.9
|
208.9
|
191.3
|
83.03
|
770.4
|
Operating Margin
|
4.52%
|
6.3%
|
7.93%
|
8%
|
2.87%
|
17.35%
|
Earnings before Tax (EBT)
1 |
21.81
|
111.9
|
197.9
|
176.3
|
75.51
|
733.7
|
Net income
1 |
13.39
|
54.7
|
59.87
|
81.09
|
62.11
|
564.3
|
Net margin
|
0.81%
|
2.45%
|
2.27%
|
3.39%
|
2.14%
|
12.71%
|
EPS
2 |
1.710
|
6.985
|
7.646
|
10.36
|
7.930
|
72.07
|
Free Cash Flow
1 |
24.24
|
16.86
|
343.9
|
-155.3
|
61.15
|
160.2
|
FCF margin
|
1.47%
|
0.75%
|
13.05%
|
-6.49%
|
2.11%
|
3.61%
|
FCF Conversion (EBITDA)
|
29.83%
|
11.54%
|
160.27%
|
-
|
65.53%
|
20.55%
|
FCF Conversion (Net income)
|
181.02%
|
30.83%
|
574.44%
|
-
|
98.45%
|
28.4%
|
Dividend per Share
|
-
|
-
|
2.000
|
-
|
1.500
|
8.000
|
Announcement Date
|
24/08/18
|
14/08/19
|
07/09/20
|
11/08/21
|
10/08/22
|
23/08/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
384
|
337
|
-
|
75.5
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
36
|
-
|
1.4
|
452
|
Leverage (Debt/EBITDA)
|
4.725
x
|
2.304
x
|
-
|
0.3718
x
|
-
|
-
|
Free Cash Flow
1 |
24.2
|
16.9
|
344
|
-155
|
61.1
|
160
|
ROE (net income / shareholders' equity)
|
1.98%
|
7.75%
|
7.95%
|
9.97%
|
7.02%
|
47.4%
|
ROA (Net income/ Total Assets)
|
3.22%
|
5.57%
|
8.41%
|
8.86%
|
3.52%
|
26.6%
|
Assets
1 |
416.2
|
981.7
|
711.7
|
915
|
1,765
|
2,121
|
Book Value Per Share
2 |
86.60
|
93.50
|
98.70
|
109.0
|
117.0
|
187.0
|
Cash Flow per Share
2 |
0.0800
|
5.670
|
4.590
|
1.610
|
0.4000
|
0.1100
|
Capex
1 |
4.18
|
1.94
|
8.75
|
7.66
|
2.89
|
4.97
|
Capex / Sales
|
0.25%
|
0.09%
|
0.33%
|
0.32%
|
0.1%
|
0.11%
|
Announcement Date
|
24/08/18
|
14/08/19
|
07/09/20
|
11/08/21
|
10/08/22
|
23/08/23
|
|
1st Jan change
|
Capi.
|
---|
| +1.34% | 26.17M | | +5.97% | 105B | | -4.19% | 63.99B | | +51.90% | 42.95B | | +17.44% | 39.2B | | +6.62% | 33.01B | | +13.00% | 20.33B | | +15.64% | 17.29B | | +22.55% | 15.72B | | +7.34% | 14.72B |
Other Commodity Chemicals
|